Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thiamine Intervention and Cognition in Older Adults Undergoing CABG
NCT06326996Phase 1Recruiting
- Sponsor
- University of California, Los Angeles
- Start
- Oct 2024
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in coronary heart disease (CHD) comparing Thiamine Treatment with Placebo Treatment (2 arms). Primary endpoints: Effects of thiamine treatment intervention on blood lactate levels at 1 month, Effects of thiamine treatment intervention on blood thiamine levels at 1 month and 5 more. Started Oct 2024; status: recruiting.
02
Drugs
thiamine
03
Conditions
coronary heart disease (CHD)
Beyond the preview
Go deeper on NCT06326996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06326996.